Health

A groundbreaking trial, known as the Renal Agenesis Fetal Therapy (RAFT) trial, has shown promising results in restoring amniotic fluid lost due to fetal renal underdevelopment before 26 weeks’ gestation. The study found that serial infusions of amniotic fluid significantly increased the rate of live births without posing any major risks to the mothers involved.
0 Comments
In a randomized IMerge trial, patients with lower-risk myelodysplastic syndromes (MDS) who relapsed or were refractory to standard treatment achieved improved rates of red blood cell (RBC) transfusion independence with an investigational, first-in-class telomerase inhibitor called imetelstat. This breakthrough therapy showed promising results in achieving sustained transfusion independence and potentially serving as a second-line treatment
0 Comments
The so-called “Take Care of Maya” trial concluded recently, resulting in a substantial $261 million verdict against Johns Hopkins All Children’s Hospital of Florida. The jury found the hospital liable for various claims, including wrongful death, emotional distress, false imprisonment, and battery. The Kowalski family alleged that the hospital falsely reported Medical Child Abuse (MCA)
0 Comments
The International Gynecologic Cancer Society (IGCS) annual meeting recently featured the presentation of updated results from a phase I study on the investigational bispecific antibody ubamatamab (REGN4018). This antibody, when used alone or in combination with the PD-1 inhibitor cemiplimab (Libtayo), demonstrated both safety and activity in patients with recurrent ovarian cancer. In this article,
0 Comments
Thyroidectomy, the surgical removal of the thyroid gland, has been shown to significantly improve the general health and quality of life in patients with euthyroid Hashimoto’s thyroiditis. A recent extension of a randomized trial conducted by Geir Hoff, MD, PhD, and colleagues from the University of Oslo in Norway, revealed that the positive impact on
0 Comments
Stand-up comedy may not be the typical medium for delivering important messages, but Amy Schumer managed to make a profound point about the state of women’s health research. In her comedy special, Schumer shared her experience with a pregnancy condition called hyperemesis gravidarum and highlighted the lack of scientific knowledge surrounding it. This specific insight
0 Comments